• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Potential gains and costs from increasing access to thrombolysis for acute ischemic stroke patients in New Zealand hospitals
ConclusionWhile thrombolysis is a cost‐effective treatment in New Zealand, resources should be devoted to campaigns, both within hospitals and in the community, to increase coverage.
Source: International Journal of Stroke - November 10, 2013 Category: Neurology Authors: Braden Te Ao, Paul Brown, John Fink, Mark Vivian, Valery Feigin Tags: Research Source Type: research

Stroke prevention in New Zealand: Can we do better?
There are approximately 45 000 stroke survivors in New Zealand and this number is projected to increase to 50 000 survivors, with annual costs to the health system exceeding $700 million by 2015 if no effective primary stroke prevention strategies are introduced. However, development of evidence‐based stroke prevention strategies requires answering several research questions. In this article, we summarize some key research questions that are particularly pertinent to stroke prevention in New Zealand.
Source: International Journal of Stroke - October 27, 2013 Category: Neurology Authors: Valery L. Feigin, Rita Krishnamurthi, P. Alan Barber, Bruce Arroll Tags: Leading Opinion Source Type: research